2139 results about "Lost Weight" patented technology

The present invention provides a low-lipid, high-fiber, balanced-nutritional, instant-taking and instant-resolving powder made from all natural components including corn, bean, flower, vegetable, fruit, tea and bi-usage plants for both food and medication. The nutritional powder provided by the present invention has not only the functions to balance the nutrition, but also the effect to decrease the body weight, lower the blood glucose, and effectively prevent and treat the diabetes.

The present invention relates to a treatment of obesity, and in particular to a therapeutic method belonging to a surgical field for obesity wherein it is possible to reduce a calorie intake amount and to lose weight using a gastroscope used for endoscopic examination of the stomach in such a manner that a certain balloon is inserted in the interior of stomach of fat person for thereby decreasing the entire volume of stomach, so that a user feels a earlier fullness during eating food thus decreasing the amount of food intake.

A method for increasing metabolism of a subject's body in order to lose weight, comprising:a) contacting a part of the body with a cooling element to remove heat from the body; andb) repeating or continuing (a) so as to remove enough heat in total to lose at least 1 kilogram of body weight.

Systems and methods for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and treating hyperglycemia, Alzheimer's disease, sleep disorders, Parkinson's disease, Attention Deficit Disorder and nicotine addiction involve synchronizing and tailoring the administration of nutraceuticals, medications and other substances (for example, stimulants) in accordance with the body's natural circadian rhythms, meal times and other factors. Improved control of blood glucose levels, extended alertness, and weight control, and counteracting of disease symptoms when they are at their worst are possible. An automated, pre-programmable transdermal administration system is used to provide pulsed doses of medications, pharmaceuticals, hormones, neuropeptides, anorexigens, pro-drugs, stimulants, plant extracts, botanicals, nutraceuticals, cosmeceuticals, phytochemicals, phytonutrients, enzymes, antioxidants, essential oils, fatty acids, minerals, vitamins, amino acids, coenzymes, or other physiological active ingredient or precursor. The system can utilize a pump, pressurized reservoir, a system for removing depleted carrier solution, or other modulated dispensing actuator, in conjunction with porous membranes or micro-fabricated structures.

A sustained-release oral dosage form of naltrexone or a pharmaceutically acceptable salt thereof is provided. The oral dosage form may be administered with another compound. Administration of the oral dosage form may reduce a side effect, which may be a side effect at least partially attributable to a weight-loss treatment. The oral dosage form may be administered to treat a weight-loss condition.

An automated identification, weight measurement and data reporting system that allows users to have their weight measured at a remote location and sent electronically to a data center. The invention can use biometric identification technology to confirm the identity of the user at the time of the measurement of the user's weight. The user's body weight may be measured via an electronic scale connected to the biometric identification device. The measurement data is then sent via a network (such as the Internet) to a central database. This secure weight measurement data is then used to offer incentives to individuals to lose weight. The more weight an individual loses, the larger the earned incentives. The invention also includes programs to measure health functions and to provide incentives to improve their health including body fat reduction, quitting smoking, reducing their blood pressure, or other health function.

A compound which is 3-hydroxybutyl 3-hydroxybutyrate enantiomerically enriched with respect to (3R)-hydroxybutyl (3R)-hydroxybutyrate of formula (I) is an effective and palatable precursor to the ketone body (3R)-hydroxybutyrate and may therefore be used to treat a condition which is caused by, exacerbated by or associated with elevated plasma levels of free fatty acids in a human or animal subject, for instance a condition where weight loss or weight gain is implicated, or to promote alertness or improve cognitive function, or to treat, prevent or reduce the effects of neurodegeneration, free radical toxicity, hypoxic conditions or hyperglycaemia.

Devices for treatments of diseases and disorders associated with the gastrointestinal tract, especially the stomach, or urinogenital tract are described herein. Initially, the device is in a temporary form which is suitable for oral or rectal administration. After exposure to a stimulus, such as a temperature or pH change, the device changes shape to a permanent form, which allows it to become mechanically fixed in the stomach, esophagus or intestine. In one embodiment, the device is used to reduce the volume of the stomach, esophagus or intestine without interfering with the flow of the food through the gastrointestinal tract. The device may be used to help overweight patients lose weight and to deliver drugs to treat disorders and diseases in the in the stomach or intestine. The devices are manufactured from a stimuli-sensitive polymeric material, which is biocompatible and primarily adapted to the mechanical properties and geometry in the area to which it is applied. In the preferred embodiment, the material is a shape memory polymer. Depending on the desired application, the polymer may be either biodegradable or non-degradable.

This invention relates to a nutritional intervention composition for enhancing satiety prior to a meal and extending satiety after a meal. The nutritional intervention composition decreases food intake producing weight loss over time. The composition consists of Niacin, Vitamin B6, Calcium, Phosphorous, Magnesium, Chromium, Chitosan, Fenugreek, Ginseng, White willow bark, Garcinia cambogia, Aloe Vera gel powder, Momordica charantia, Griffonia simplicifolia, Lagerstroemia speciosa and Vanadyl sulfate. The invention does not require stimulants or anabolic ingredients. There are three phases of activity within the composition. One, enhanced satiety through elevated serotonin. Two, improved carbohydrate metabolism, reduced blood glucose and slowed gastric emptying. Three, enhanced fiber binding of lipids and excess bile acids.

The invention provides materials and methods for promoting weight loss or preventing weight gain, and in the treatment of diabetes and associated metabolic disorders. In particular, the invention provides novel acylated glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

Compositions and methods useful for inducing an increase in fatty acid oxidation or mitochondrial biogenesis, reducing weight gain, inducing weight loss, or increasing Sirt1, Sirt3, or AMPK activity are provided herein. Such compositions can contain synergizing amounts of a sirtuin-pathway activators, including but not limited to resveratrol, in combination with beta-hydroxymethylbutyrate (HMB), keto isocaproic acid (KIC), leucine, or combinations of HMB, KIC and leucine.

Methods and devices are provided for adjusting the height of devices in a gastric restriction system. In general, the methods and devices allow one or more implantable housings coupled to an implantable restriction device to have an adjustable height. The housing can include, for example, a fill port housing, a sensor housing, and any other type of housing that can be used in an implantable restriction system and desired to have an adjustable height. The housing can lower in profile over time, e.g., as the patient loses weight, thereby maintaining the housing in a generally predictable location where it can be found and accessed.

In various embodiments, the present invention is directed to a taste masked pharmaceutical composition comprising a therapeutically effective amount of taste masked sulfamate-substituted monosaccharide particles comprising a sulfamate-substituted monosaccharide or a pharmaceutically acceptable salt or derivative thereof that are coated with one or more taste-masking layers, and optionally one or more of taste-masked neltrexone, 5-HT3 receptor antagonist, phentermine, and vitamin B-12. The present invention relates to methods of making the taste masked and ODT compositions, and methods of using the compositions for treating a patient subject to an epileptic condition, migraines, dysphagia, achieving / maintaining weight loss, or alcoholism or drug addiction.

Beta-hydroxybutyrate mineral salts in combination with medium chain fatty acids or an ester thereof such as medium chain triglycerides were used to induce ketosis, achieving blood ketone levels of (2-7 mmol / L), with or without dietary restriction. The combination results in substantial improvements in metabolic biomarkers related to insulin resistance, diabetes, weight loss, and physical performance in a short period of time. Further, use of these supplements to achieve ketosis yields a significant elevation of blood ketones and reduction of blood glucose levels. Use of these substances does not adversely affect lipid profiles. By initiating rapid ketosis and accelerating the rate of ketoadaptation, this invention is useful for the avoidance of glucose withdrawal symptoms commonly experienced by individuals initiating a ketogenic diet, and minimizes the loss of lean body mass during dietary restriction.

Beta-hydroxybutyrate mineral salts in combination with medium chain fatty acids or an ester thereof such as medium chain triglycerides were used to induce ketosis, achieving blood ketone levels of (2-7 mmol / L), with or without dietary restriction. The combination results in substantial improvements in metabolic biomarkers related to insulin resistance, diabetes, weight loss, and physical performance in a short period of time. Further, use of these supplements to achieve ketosis yields a significant elevation of blood ketones and reduction of blood glucose levels. Use of these substances does not adversely affect lipid profiles. By initiating rapid ketosis and accelerating the rate of ketoadaptation, this invention is useful for the avoidance of glucose withdrawal symptoms commonly experienced by individuals initiating a ketogenic diet, and minimizes the loss of lean body mass during dietary restriction.

The present invention features a novel therapy for effecting weight loss which involves treating a subject with a sympathomimetic agent (e.g., phentermine or a phentermine-like drug) in combination with an anticonvulsant sulfamate derivative (e.g., topiramate) such that the subject experiences weight loss.The combination methods of the present invention also are effective against symptoms associated with Syndrome X. The invention also features pharmaceutical compositions and kits for use in the practice of these novel therapies.

A compound which is 3-hydroxybutyl 3-hydroxybutyrate enantiomerically enriched with respect to (3R)-hydroxybutyl (3R)-hydroxybutyrate of formula (I) is an effective and palatable precursor to the ketone body (3R)-hydroxybutyrate and may therefore be used to treat a condition which is caused by, exacerbated by or associated with elevated plasma levels of free fatty acids in a human or animal subject, for instance a condition where weight loss or weight gain is implicated, or to promote alertness or improve cognitive function, or to treat, prevent or reduce the effects of neurodegeneration, free radical toxicity, hypoxic conditions or hyperglycaemia.

A computer program, method, and system for dynamically and interactively providing nutrition content information for consumables such that a user may monitor, tailor, plan, and review their intake thereof in light of a health-related interest or concern, such as, for example, weight-loss, food allergies, or diabetes or other nutrition affected illnesses or disabilities. Consumables are categorized and displayed in lists associated with an appropriate color to draw attention to relative nutrition content and to facilitate quicker and easier evaluation of a consumable of interest. Summaries are provided of a user's actual intake in light of a pre-established target intake for a particular day. Detailed reports may be generated showing consumption over a user-specifiable time period.

The invention relates to integrated enzyme powder having effects of reducing fat and losing weight. The integrated enzyme powder is characterized by being prepared from powders which are, by weight parts, 62.8-71.8 parts of integrated enzyme raw powder, 8-15 parts of konjac flour, 10 parts of pumpkin powder, 1 part of papaya powder, 3 parts of pineapple powder, 1 part of mango powder, 1 part of sweet orange powder, 1 part of snow pear powder, 3-5 parts of dietary fiber powder and 0.2 part of compound lactobacillus powder. 43 fruits, 20 vegetables, 4 cereal nuts and 11 medicinal and edible herbaceous plants and natto are selected in total to serve as fermentation raw materials; through yeast and lactobacillus fementation, generated enzymes are total nutrients needed by humans, and the enzyme powder contains activity probiotics which are resistant to acid and heat; and through testing, the probiotics in artificial gastric juice still have ultrahigh vigor; at normal temperature (37 DEG C), the probiotics still maintain activity, can regulate intestinal flora of the human body, promote digestion and avoid constipation. The mixed integrated enzyme powder not only can achieve the goal of losing weight, but also can meet the basic nutrition requirements of the human body, and it is a healthy and effective method of reducing fat and losing weight to use the enzyme powder.

The invention relates to a traditional Chinese medicine health care type pet food for cats and dogs, comprising the following components: animal protein, vegetable protein, carbohydrate, flaxseed oil, antioxidant, multi-vitamin, mineral substance, seaweed and natural fermentation seafood seasoner. The invention is characterized in that the pet food contains milk veteh, rhizoma atractylodis alba, medicated leaven, dyer woad leaf and lotus leaf. The pet food of the invention has the following beneficial effects: the pet food has total nutrition and health care function; the added milk veteh contributes to replenishing qi and improving immunity and disease-resistance capability of pets, the rhizoma atractylodis alba and medicated leaven can help improve the appetite of pets and promote the digestion thereof, the dyer woad leaf can help resist virus and eliminate minor inflammation, while the lotus leaf can help the pets lose weight with ease without food amount restriction. In the invention, comparative trials are carried out on pet cats and pet dogs, results show that the capability of resisting disease of the pet cats and pet dogs eating the pet food of the invention are twice as that of the pet cats and pet dogs eating ordinary pet food; in addition, skin and hair thereof are obviously smooth and soft, body thereof is sturdy and mobility and playfulness thereof are also improved; moreover, no pets put on weight while not resisting food amount.

The invention discloses a fruit and vegetable juice, a fruit and vegetable juice beverage and a preparation method of the fruit and vegetable juice. The preparation method of the fruit and vegetable juice comprises the following steps: (1) selecting and cleaning fruits and vegetables; (2) preparing raw fruit and vegetable juice; (3) carrying out cold enzyme deactivation and color protection treatment on the raw juice; (4) carrying out enzymolysis treatment; (5) carrying out refined filtration and hollow filtration; (6) carrying out low-temperature vacuum concentration; and (7) carrying out a cold sterilization procedure. According to the fruit and vegetable juice and the fruit and vegetable juice beverage prepared by the method, cold enzyme deactivation and cold sterilization technologies are adopted for the fruit and vegetable juice in enzyme deactivation and sterilization, so that the prepared fruit and vegetable juice and the fruit and vegetable juice beverage completely reserve nutritive value and health functions of fresh fruits and vegetables, and have the health functions of clearing heat, removing internal heat, promoting the secretion of saliva or body fluid, quenching thirst, moistening the lung, removing fat, lowering pressure, detoxifying, dispelling the effects of alcohol, inducing diuresis, reducing swelling, and losing weight.

The invention provides materials and methods for promoting weight loss or preventing weight gain, and in the treatment of diabetes, metablic syndrome and associated disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

An apparatus that provides for the measurement of a person's weight via a portable remote readout located at eye-level. The weight measuring device comprises a low profile mat with weight sensors that are activated whenever someone steps on the mat. The sensors communicate a sensor weight signal to a transmitter, which in turn communicates the weight signal to a receiver preferably located at eye-level and provided with a variety of mounting means. A preferred embodiment provides for a magnet which enables mounting of the receiver on a refrigerator door. Such a location is envisioned to provide an incentive for those trying to lose weight, by providing one's current weight on the refrigerator door to avoid any unnecessary snacks.

The present system combines image morphing technology, exercise programming, supplement sales, and motivational techniques into one product. Users begin by entering their current measurements, measurement goals and current picture into the system, preferably via a Web site. The picture is segmented into body components, and each affected segment is morphed based upon the measurements, goals, and the segment's responsiveness to weight loss in order to create a modified image representative of the user in a post-regimen condition. This system helps health and fitness businesses obtain new members and retain existing members by showing the members how they will look after following a specific regimen of diet and / or exercise. The system also predicts health risks of diabetes, heart disease, and stroke associated with the user's pre-regimen and post-regimen conditions.

The invention discloses a functional fruit and vegetable can and a production process thereof. The invention is mainly characterized in that according to four properties and five flavors of food and drugs as well as functions of food and drugs, the combination of the two can lead the properties and flavors to be matched, power to help with each other, to be mutually promoted and mutually assisted, power to be greatly increased, and to be used for supplementing body and treating diseases. The invention mainly adopts fruits and vegetables and traditional Chinese herbs capable of being used as both medicine and food so as to inherit and develop dietotherapy of the Chinese tradition according to the properties and flavors and work out scientific formula for combining a traditional can production technology and a modern technology, thus forming modern agricultural high and new technology industry. The scientific production method and the new technology process are invented, and the functional fruit and vegetable can comprises the following compositions: organic fruits, mixed fruits, medicine-drug dual-use Chinese herbal medicine, nutrient and trace element. The functional fruit and vegetable can has the effects of treating and preventing diabetes mellitus, lowering blood lipid and blood pressure, losing weight, preventing having a cold, relieving cough and reducing sputum, improving appetite and promoting digestion, tonifying Qi and enriching the blood, invigorating the brain and benefiting the intelligence, nourishing yin for suppressing hyperactive yang, stablizing teeth and growing hair, and beautifying and moisturizing.

The invention provides materials and methods for promoting weight loss or preventing weight gain, and in the treatment of diabetes, metablic syndrome and associated disorders. In particular, the invention provides novel glucagon analogue peptides effective in such methods. The peptides may mediate their effect by having increased selectivity for the GLP-1 receptor as compared to human glucagon.

The invention discloses a nutritious food especially for diabetes patient and a manufacturing method. The nutritious food consists, according to the weight percentage, of 8 percent to 16 percent of tuckahoe, 8 percent to 16 percent of medlar, 8 percent to 16 percent of white hyacinth bean, 6 percent to 12 percent of semen phaseoli, 8 percent to 16 percent of tartary buck wheat, 3 percent to 10 percent of chitosan, 3 percent to 10 percent of dioscorea opposite, 3 percent to 10 percent of coix seed, 3 percent to 12 percent of isolated protein of peanut, 1 percent to 5 percent of whey condensed protein, 3 percent to 10 percent of sealwort, and 3 percent to 10 percent of polygonatum. The above nutritious food also consists of one or a plurality of kinds of the following componets: 0.5 percent to 2 percent of spirulina platensis, 0.5 percent to 2 percent of low ester pectin, 1 percent to 5 percent of cinnamon, 1 percent to 5 percent of cactus, 1 percent to 5 percent of balsam pear, 0.04 percent to 0.2 percent of tea polyphenols, 0.03 percent to 0.05 percent of zinc gluconate, 0.0001 percent to 0.0005 percent of sodium selenite, 1 percent to 4 percent of milk calcium, 0.2 percent to 0.8 percent of magnesium carbonate, 0.1 percent to 0.5 percent of vitamin C, 0.01 percent to 0.05 percent of vitamin B1, and 0.01 percent to 0.05 percent of vitamin B2. The invention has a double regulation function of the blood sugar of diabetes patients, helps diabetes patients to keep the relative stability of the blood sugar, and at the same time reduces the sense of hunger, thus beneficial to lose weight and reduce blood fat. The invention supplements nutrition and is beneficial to cooperate with the diet control and treatment of diabetes patients.

The invention discloses a nutrition meal replacement composition, which is prepared from the following components in parts by weight: 10-300 parts of euglenophyta powder, 60-500 parts of quinoa powder, 100-400 parts of chia seed powder, 40-450 parts of collagen powder, 50-520 parts of a carbohydrate compound, 0-200 parts of vitamin and 0-500 parts of mineral substances. The invention further discloses a nutrition meal replacement refresher. The refresher is prepared from the nutrition meal replacement composition and a food additive. The nutrition meal replacement composition has the effects of regulating intestinal tracts, dual-directionally regulating blood glucose and providing abundant nutrient substances needed for a human body while losing weight and controlling the weight.